Ef Therapeutics Corp.

Palmetto, FL

UEI
X42PJJN1JGE3
CAGE
13UW7
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2235 36th Ave E, Palmetto, FL 34221, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Ef Therapeutics Corp.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Intellipulsetm platform technology for effective delivery of therapeutic agents - the long-term goal of EF… Grant · R44CA298522 National Cancer Institute $2,045,575
Identification of impedance measurement devices, heating hardware, and operating parameters to augment instrumentation… Grant · R41GM146569 National Institute of General Medical Sciences $451,644

Quick answers

What is Ef Therapeutics Corp.'s UEI?

Ef Therapeutics Corp.'s Unique Entity ID (UEI) in SAM.gov is X42PJJN1JGE3.

What is Ef Therapeutics Corp.'s CAGE code?

Ef Therapeutics Corp.'s CAGE code is 13UW7.

What is Ef Therapeutics Corp.'s primary NAICS code?

Ef Therapeutics Corp.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Ef Therapeutics Corp. located?

Ef Therapeutics Corp.'s physical address in SAM.gov is 2235 36th Ave E, Palmetto, FL 34221, USA.

Is Ef Therapeutics Corp. registered in SAM.gov?

Yes. Ef Therapeutics Corp.'s SAM.gov registration is active through February 23, 2027.

What is Ef Therapeutics Corp.'s most recent federal award?

Ef Therapeutics Corp.'s most recent federal grant award is Intellipulsetm platform technology for effective delivery of therapeutic agents - the long-term goal of EF… (R44CA298522), from National Cancer Institute, on September 4, 2025.

On GovTribe

See Ef Therapeutics Corp.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login